Clearing Pollution Helps Clear the Fog of Aging — And May Cut the Risk of Dementia
Two studies published this year provide evidence that older adults’ cognitive health may benefit if air quality is improved.
Dementia
21 - 40 of 84 Results
-
-
Hospices Have Become Big Business for Private Equity Firms, Raising Concerns About End-of-Life Care
Private equity firms are seeing opportunities for profit in hospice care, once the domain of nonprofit organizations. The investment companies are transforming the industry — and might be jeopardizing patient care — in the process.
-
KHN’s ‘What the Health?’: Leaked Abortion Opinion Rocks Washington’s World
The unprecedented early leak of a Supreme Court draft opinion that would overturn the landmark abortion-rights ruling Roe v. Wade has heated the national abortion debate to boiling. Meanwhile, the FDA, after years of consideration, moves to ban menthol flavors in cigarettes and cigars. Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, Shefali Luthra of the 19th, and Jessie Hellmann of CQ Roll Call join KHN’s Julie Rovner to discuss these issues and more. Plus, Rovner interviews KHN’s Paula Andalo, who wrote the latest KHN-NPR “Bill of the Month” episode about a family whose medical debt drove them to seek care south of the border.
-
Patients Divided Over Alzheimer’s Drug: Is It a ‘Risk I’m Willing to Take’ or Just a ‘Magic Pill’?
Medicare has proposed limiting coverage of Aduhelm, the costly new drug to treat Alzheimer’s disease, and several prominent groups representing patients and their families are pressing the program to make it more widely available. But among individuals facing the disease, the outlook is more nuanced.
-
Watch: Seniors Share How They’ve Made It Through the Pandemic
Nine seniors from across the country talk frankly about feeling alone and constrained, missing church, and family routines. They also share newfound hope and discoveries that arose from the crisis.
-
KHN’s ‘What the Health?’: Dealing With Drug Prices
Medicare officials tentatively plan to restrict the use of a controversial Alzheimer’s drug to only those patients participating in clinical trials, while the Department of Health and Human Services looks into lowering the monthly Medicare Part B premium. Meanwhile, covid confusion still reigns, as the Biden administration moves, belatedly, to make more masks and tests available. Joanne Kenen of Politico and the Johns Hopkins Bloomberg School of Public Health, Sarah Karlin-Smith of the Pink Sheet and Rachel Cohrs of Stat join KHN’s Julie Rovner to discuss these issues and more.
-
Q&A
Wartime Trauma Hits Close to Home for Scholar of Dementia
The federal government is putting up $7.2 million for a study into the correlation between war trauma and dementia in Vietnamese immigrants. Oahn Meyer, an associate professor at the University of California-Davis who is leading the study, wonders whether her mother’s dementia is linked to trauma she suffered during the Vietnam War.
-
When the Eye on Older Patients Is a Camera
High-tech tools ease caregivers’ stress but can raise sticky privacy questions and concerns about cost.
By Sofie Kodner -
Alzheimer’s Drug Targets People With Mild Cognitive Impairment. What Does That Mean?
The condition can be an early signal of Alzheimer’s disease, but not always. Other health concerns could be causing thinking or memory problems, and the new drug, Aduhelm, would not be appropriate for those patients.
-
Facing Headwinds on New Alzheimer’s Drug, Biogen Launches Controversial Campaign
The makers of Aduhelm, a drug approved last month despite concerns raised by experts about its effectiveness, have launched a website and ads designed to urge people who are worried about their memory to ask doctors about testing. But some health advocates say it is misleading because some memory loss with aging is normal.
-
Doctors Weigh Pros and Cons of Prescribing Hot-Button Alzheimer’s Drug
The potential benefits of Aduhelm are small, its effectiveness is not certain, and even the FDA Thursday shifted its guidance on who should get the drug. But physicians are dealing with an onslaught of interest from patients and their families, and figuring out which patients are best positioned to be helped by the drug will be difficult.
-
Violent Colorado Arrest Puts Spotlight on How Police Treat Disabled People
Criminal charges filed against two officers who injured a Colorado woman with dementia don’t address the fact that police often lack the skills to effectively deal with suspects with mental disabilities.
-
KHN’s ‘What the Health?’: Our 200th Episode!
The federal approval of a controversial drug to treat Alzheimer’s disease has reignited the debate over drug prices and the way the Food and Drug Administration makes decisions. Meanwhile, President Joe Biden seeks to gain goodwill overseas as he announces the U.S. will provide 500 million doses of covid vaccine to international health efforts. Sarah Karlin-Smith of the Pink Sheet, Margot Sanger-Katz of The New York Times and Joanne Kenen of Politico join KHN’s Julie Rovner to discuss these issues and more. Also, Rovner interviews Chiquita Brooks-LaSure, the new administrator of the Centers for Medicare & Medicaid Services. And to mark the podcast’s 200th episode, the panelists discuss what has surprised them most and least over the past four years.
-
Aiding Her Dying Husband, a Geriatrician Learns the Emotional and Physical Toll of Caregiving
When the covid pandemic hit, Dr. Rebecca Elon was thrust into a new role, primary caregiver for her severely ill husband and her elderly mother. “Reading about caregiving of this kind was one thing. Experiencing it was entirely different,” she says.
-
Trouble Managing Money May Be an Early Sign of Dementia
Long before they receive a dementia diagnosis, many people begin to mismanage their finances as their memory, organizational skills and self-control falter.
-
After Nearly 60 Years of Marriage, This Missouri Couple Stayed Together to the End
Arthur and Maggie Kelley of St. Louis died 30 days apart. Maggie died of complications of dementia in November. Arthur, who had moved into her nursing home to be with her, died a month later of covid. Their family held a double funeral.
By Cara Anthony -
If I Have Cancer, Dementia or MS, Should I Get the Covid Vaccine?
Older patients with cancer, dementia or other serious illnesses should check with their doctors, but medical experts recommend the vaccine for most people.
-
Isolation, Disruption and Confusion: Coping With Dementia During a Pandemic
COVID-19 has upended the lives of people with dementia, limiting their interactions with others and complicating matters for their caregivers.
-
U.S. Medical Panel Thinks Twice About Pushing Cognitive Screening For Dementia
Because seniors are at higher risk of cognitive impairment, proponents say screening asymptomatic older adults is an important strategy to identify people who may be developing dementia and to improve their care. But the U.S. Preventive Services Task Force cited insufficient evidence the tests are helpful.
-
Stalked By The Fear That Dementia Is Stalking You
For those worried they have an elevated risk of Alzheimer’s and other forms of dementia, testing is an option. But words to the wise: It’s hardly foolproof and could even backfire by heightening your fear of memory loss.